Episodes
In this week’s View, Dr. Eagle discusses trends in the use of oral anticoagulants in older adults with newly diagnosed atrial fibrillation, then looks at a collaborative meta-analysis of large placebo-controlled trials that examines the impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes. Finally, Dr. Eagle explores insights from the PEGASUS-TIMI 54 trial regarding patient selection for long-term secondary prevention with ticagrelor. Subscribe...
Published 11/23/22
In this week’s View, Dr. Eagle discuses hypertension management in patients with cardiovascular comorbidities, then looks at a patient-level analysis of Phase III trials that examines Inclisiran and cardiovascular events. Finally, Dr. Eagle explores the STROKESTOP study on the cost-effectiveness of population screening for atrial fibrillation. Subscribe to Eagle’s Eye View
Published 11/16/22
In this week’s View, Dr. Eagle discusses the most important aspects of the new ACC AHA Guidelines for the diagnosis and management of aortic disease. Subscribe to Eagle’s Eye View  
Published 11/09/22
Drs. Deepak Bhatt, Kim Eagle and Payal Kohli review Day 3 late-breaking science from AHA 2022, including ENHANCE-AF (0:32), PRECSION (2:40), BrightHTN (4:08), and SPYRAL HTN-ON (6:41). The ACC is providing coverage of the hottest AHA 2022 science. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage page and follow the ACC on social media using the hashtag #AHA22 to join the conversation.
Published 11/07/22
Drs. Deepak Bhatt, Kim Eagle and Payal Kohli review Day 2 late-breaking science from AHA 2022, including ECMO-CS (0:42), RESPECT-EPA (2:22), ISCHEMIA-EXTENDed (5:45) and EMPA-KIDNEY (7:39). The ACC is providing coverage of the hottest AHA 2022 science. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage page and follow the ACC on social media using the hashtag #AHA22 to join the conversation.
Published 11/07/22
In this special AHA episode of Eagle’s Eye View, Drs. Deepak Bhatt, Kim Eagle and Payal Kohli discuss highlights from Day 1 of the AHA 2022 late-breaking science, including TRANSFORM-HF, DCP, PROMINENT, and IRONMAN. The ACC is providing coverage of the hottest AHA 2022 science. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage page and follow the ACC on social media using the hashtag #AHA22 to join the conversation.
Published 11/05/22
In this week’s View, Dr. Eagle discusses a secondary analysis of the REPRISE III randomized clinical trial on long-term outcomes of transcatheter aortic valve replacement with the Lotus valve vs the CoreValve/EvolutR, then looks at iron deficiency and cardiovascular disease. Finally, Dr. Eagle explores the association of race and ethnicity with oral anticoagulation and associated outcomes in patients with atrial fibrillation. Subscribe to Eagle’s Eye View
Published 11/02/22
In this episode, guest host Deepak Bhatt, MD, MPH, FACC, offers a preview of some of the most important and clinically transformative studies being presented at the AHA 2022 Conference, November 5-7. Day One includes two major studies on diuretics: primary results from the TRANSFORM HF Trial, examining the comparative effectiveness of torsemide versus furosemide in heart failure, and from the DCP Trial on chlorthalidone compared to hydrochlorothiazide for the prevention of cardiovascular...
Published 10/28/22
In this week’s View, Dr. Eagle discusses the European Atherosclerosis Society’s consensus statement on lipoprotein(a) [Lp(a)] in atherosclerotic cardiovascular disease (ASCVD) and aortic valve stenosis, then looks at CHD screening in kidney and liver transplant candidates.
Published 10/26/22
In this week’s View, Dr. Eagle discusses the TIME Study, a prospective, randomized, open-labe,l blinded-endpoint clinical trial exploring cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives, then looks at phenotyping the hypertensive heart. Finally, Dr. Eagle takes a look at a multinational study on programmed ventricular stimulation as an additional primary prevention risk stratification tool in arrhythmogenic right ventricular...
Published 10/19/22
In this week’s View, Dr. Deepak Bhatt sits in for Dr. Eagle to discuss TIMING, a registry-based randomized controlled noninferiority study that examines early versus delayed non–Vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation, then looks at the Fingersture study on plaque histology and myocardial disease in sudden coronary death. Finally, Dr. Bhatt takes a look at a recent paper on evolving management concepts for left main coronary disease. ...
Published 10/12/22
In this week’s View, Dr. Eagle discusses the Fitbit Heart Study that examines the detection of atrial fibrillation in a large population using wearable devices, then looks at the long-term effects of P2Y12 inhibitor monotherapy after percutaneous coronary intervention. Finally, Dr. Eagle discusses risk assessment of hypertensive events during pregnancy. Subscribe to Eagle’s Eye View
Published 10/05/22
In this week’s View, Dr. Eagle discusses a scientific statement from the American Heart Association on the management of patients at risk for and with left ventricular thrombus, then looks at the nationwide CONCEPTION study concerning pregnancy and the onset of chronic hypertension. Finally, Dr. Eagle examines the risk for myocardial infarction, stroke, and pulmonary embolism following COVID-19 vaccines in adults younger than 75 years of age in France. Subscribe to Eagle’s Eye View
Published 09/28/22
In this special episode of Eagle’s Eye View, Drs. Deepak Bhatt, Bina Ahmed and Roxana Mehran discuss highlights from Day 3 of the TCT 2022 late-breaking science, including PCSK9 Inhibition, FAVOR III China, and SCAAR. The ACC is providing coverage of the hottest TCT 2022 science. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC’s Meeting Coverage page and follow the ACC on social media using the hashtag #TCT2022 to join the conversation.
Published 09/19/22
In this special episode of Eagle’s Eye View, Drs. Deepak Bhatt, Bina Ahmed and Roxana Mehran discuss highlights from Day 2 of the TCT 2022 late-breaking science, including RADIANCE II, SYMPLICTY HTN-3, pulmonary denervation, and UNIVERSAL. The ACC is providing coverage of the hottest TCT 2022 science. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC’s Meeting Coverage page and follow the ACC on social media using the hashtag #TCT2022 to join the conversation.
Published 09/18/22
In this special ESC Congress episode of Eagle’s Eye View, Drs. Deepak Bhatt, Bina Ahmed and Roxana Mehran discuss highlights from Day 1 of the TCT 2022 late-breaking science, including PROTECTED TAVR, Amulet IDE, and CLASP IID. The ACC is providing coverage of the hottest TCT 2022 science. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC’s Meeting Coverage page and follow the ACC on social media using the hashtag #TCT2022 to join the conversation.
Published 09/17/22
In this week’s View, Dr. Eagle discusses a multinational analysis with external cohort validation of sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland:, then looks at a comprehensive meta-analysis of five randomized controlled trials concerning SGLT-2 inhibitors in patients with heart failure. Finally, Dr. Eagle examines routine functional testing or standard care in high-risk patients...
Published 09/14/22
In this episode, guest host Dr. Deepak Bhatt offers a preview of some of the most important and clinically transformative studies being presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2022 conference taking place Sept. 16-19 in Boston, MA. The ACC is providing coverage of the hottest TCT 2022 science. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC’s Meeting Coverage page and follow the ACC on social media using the hashtag #TCT2022 to join the...
Published 09/13/22
In this week’s View, Dr. Deepak Bhatt sits in for the vacationing Dr. Eagle to discuss a prespecified analysis of the DELIVER Trial that investigated the efficacy and safety of dapagliflozin according to frailty in patients with heart failure, then looks at a separate paper on the DELIVER Trial that examines dapagliflozin for heart failure according to body mass index. Finally, Dr. Bhatt examines a prospective cohort study of UK Biobank participants that looked at the association between...
Published 09/07/22
In this special ESC Congress episode of Eagle’s Eye View, Drs. Deepak Bhatt, Payal Kohli, and Philippe Gabriel Steg discuss highlights from Day 4 of the ESC Congress 2022: late-breaking science and featured clinical research, including POISE-3, SPYRAL HTN-ON MED, EMPULSE, and FIDELITY.
Published 08/29/22
In this special ESC Congress episode of Eagle’s Eye View, Drs. Deepak Bhatt, Payal Kohli, and Philippe Gabriel Steg discuss highlights from Day 3 of the ESC Congress 2022: late-breaking science and featured clinical research, including INVICTUS, FACTOR XIa trials, AXIOMATIC-SSP, MOMENTUM 3, and POST-PCI.
Published 08/29/22
In this special ESC Congress episode of Eagle’s Eye View, Drs. Deepak Bhatt, Payal Kohli, and Philippe Gabriel Steg discuss highlights from Day 2 of the ESC Congress 2022: late-breaking science and featured clinical research, including DANCAVAS, REVIVED-BCIS2, ADVOR, ALL-HEART, and DELIVER.
Published 08/29/22
In this special ESC Congress episode of Eagle’s Eye View, Drs. Deepak Bhatt, Payal Kohli, and Philippe Gabriel Steg discuss highlights from Day 1 of the ESC Congress 2022: late-breaking science and featured clinical research, including SECURE, ENTRIGUE, TIME, and REDUCE-IT.
Published 08/29/22
In this week’s View, Dr. Eagle discusses the comparative risks of initial aortic events associated with genetic thoracic aortic disease, then looks at the harmonization of the American College of Cardiology/American Heart Association’s and the European Society of Cardiology/European Society of Hypertension’s Guidelines on blood pressure and hypertension. Finally, Dr. Eagle examines a study looking at how polygenic risk score may predict sudden death in patients with coronary disease and...
Published 08/24/22